The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based...

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Nutritional therapy, specifically exclusive enteral nutrition (EEN), is effective in inducing remission for active Crohn's disease (CD).
• EEN is known to modify the gut microbiota and directly reduce intestinal mucosal inflammation.
• The precise molecular mechanisms by which EEN suppresses inflammation remain largely unidentified.

Purpose of the Study:

• To investigate the primary molecular pathway through which polymeric formula (PF), a component of EEN, modulates inflammatory processes.
• To examine the effects of PF on inflammatory gene expression in intestinal epithelial cells in vitro.
• To elucidate the role of specific signaling pathways in PF-mediated anti-inflammatory effects.

Main Methods:

• Utilized microarray analysis to assess global gene expression changes in HT-29 cells treated with PF and tumor necrosis factor-alpha (TNF-α).
• Employed polymerase chain reaction (PCR) for validation of specific gene expression changes.
• Quantified cytokine protein levels (IL-6, IL-8) using enzyme-linked immunosorbent assays (ELISAs).

Main Results:

• Polymeric formula (PF) treatment modulated gene expression associated with the nuclear factor-kappa B (NF-κB) signaling pathway.
• Microarray and PCR analyses revealed downregulation of several genes within the NF-κB pathway following PF exposure.
• PF treatment led to reduced protein levels of inflammatory cytokines IL-6 and IL-8.

Conclusions:

• Polymeric formula alters inflammatory responses in intestinal epithelial cells.
• The anti-inflammatory effects of PF in CD are mediated, at least in part, through the modulation of the NF-κB pathway.
• This study provides mechanistic insights into how EEN exerts its therapeutic effects in Crohn's disease.